Spiroimidazolone derivative
US-9169254-B2 · Oct 27, 2015 · US
Spiroimidazolone derivative
US9487517B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9487517-B2 |
| Application number | US-201514857005-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 17, 2015 |
| Priority date | Apr 28, 2009 |
| Publication date | Nov 8, 2016 |
| Grant date | Nov 8, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a compound represented by the following formula (1): wherein W, X, Y, R 1 , R 2 , R 33 , R 34 , m and n are as defined in the claims, or a pharmacologically acceptable salt thereof.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound represented by the following general formula (1): wherein: W is selected from: 1) C1-C6 alkylene optionally substituted with a fluorine atom, 2) C2-C6 alkenylene, and 3) thiophene, X is a single bond, Y is an oxygen atom, m is 1; n is 1; R 1 is repr…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9487517B2 cover?
- The present invention relates to a compound represented by the following formula (1): wherein W, X, Y, R 1 , R 2 , R 33 , R 34 , m and n are as defined in the claims, or a pharmacologically acceptable salt thereof.
- Who is the assignee on this patent?
- Chugai Pharmaceutical Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D471/10. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).